Tradename | Company | Number | Date | Products |
---|---|---|---|---|
CARDIOQUIN | Pharmaceutical Research Associates Inc | N-011642 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
quinidine gluconate | ANDA | 2024-08-27 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
atrial fibrillation | EFO_0000275 | D001281 | I48.0 |
atrial flutter | EFO_0003911 | D001282 | — |
cardiac arrhythmias | EFO_0004269 | D001145 | I49.9 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pseudobulbar palsy | D020828 | EFO_1001131 | — | — | — | 1 | 3 | — | 4 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | — | 1 | — | 1 | — | 2 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | — | — | 1 | — | 1 |
Traumatic brain injuries | D000070642 | — | S06 | — | — | — | 1 | — | 1 |
Brain injuries | D001930 | — | S06.9 | — | — | — | 1 | — | 1 |
Dementia | D003704 | EFO_0003862 | F03 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sclerosis | D012598 | — | — | — | 1 | 1 | — | — | 2 |
Amyotrophic lateral sclerosis | D000690 | EFO_0000253 | G12.21 | — | — | 2 | — | — | 2 |
Pain | D010146 | EFO_0003843 | R52 | — | — | 1 | — | — | 1 |
Diabetic neuropathies | D003929 | EFO_1000783 | — | — | — | 1 | — | — | 1 |
Motor neuron disease | D016472 | EFO_0003782 | G12.2 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Schizophrenia | D012559 | EFO_0000692 | F20 | — | 1 | — | — | — | 1 |
Depression | D003863 | — | F33.9 | — | 1 | — | — | — | 1 |
Treatment-resistant depressive disorder | D061218 | — | — | — | 1 | — | — | — | 1 |
Major depressive disorder | D003865 | EFO_0003761 | F22 | — | 1 | — | — | — | 1 |
Depressive disorder | D003866 | EFO_1002014 | F32.A | — | 1 | — | — | — | 1 |
Parkinson disease | D010300 | EFO_0002508 | G20 | — | 1 | — | — | — | 1 |
Dyskinesias | D020820 | — | G24 | — | 1 | — | — | — | 1 |
Psychomotor agitation | D011595 | — | — | — | 1 | — | — | — | 1 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | 1 | — | — | — | 1 |
Neuralgia | D009437 | EFO_0009430 | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 4 | — | — | — | — | 4 |
Drug common name | Quinidine polygalacturonate |
INN | — |
Description | Quinidine is a cinchona alkaloid consisting of cinchonine with the hydrogen at the 6-position of the quinoline ring substituted by methoxy. It has a role as an alpha-adrenergic antagonist, an antimalarial, an anti-arrhythmia drug, a sodium channel blocker, a muscarinic antagonist, a potassium channel blocker, a P450 inhibitor, an EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor, an EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor and a drug allergen. It derives from a hydride of a cinchonan. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 56-54-2 |
RxCUI | 9068 |
ChEMBL ID | CHEMBL1201486 |
ChEBI ID | — |
PubChem CID | 441074 |
DrugBank | DB00908 |
UNII ID | — |